These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 11557646

  • 1. Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine.
    Scott DL, Smolen JS, Kalden JR, van de Putte LB, Larsen A, Kvien TK, Schattenkirchner M, Nash P, Oed C, Loew-Friedrich I, European Leflunomide Study Group.
    Ann Rheum Dis; 2001 Oct; 60(10):913-23. PubMed ID: 11557646
    [Abstract] [Full Text] [Related]

  • 2. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
    Kalden JR, Scott DL, Smolen JS, Schattenkirchner M, Rozman B, Williams BD, Kvien TK, Jones P, Williams RB, Oed C, Rosenburg R, European Leflunomide Study Group.
    J Rheumatol; 2001 Sep; 28(9):1983-91. PubMed ID: 11550964
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.
    Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Larsen A, Loew-Friedrich I, Oed C, Rosenburg R.
    Lancet; 1999 Jan 23; 353(9149):259-66. PubMed ID: 9929017
    [Abstract] [Full Text] [Related]

  • 4. Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazine.
    Larsen A, Kvien TK, Schattenkirchner M, Rau R, Scott DL, Smolen JS, Rozman B, Westhovens R, Tikly M, Oed C, Rosenburg R, European Leflunomide Study Group.
    Scand J Rheumatol; 2001 Jan 23; 30(3):135-42. PubMed ID: 11469522
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effects of disease-modifying anti-rheumatic drugs on the Health Assessment Questionnaire score. Lessons from the leflunomide clinical trials database.
    Scott DL, Strand V.
    Rheumatology (Oxford); 2002 Aug 23; 41(8):899-909. PubMed ID: 12154207
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Disease modification in rheumatoid arthritis with leflunomide.
    Emery P.
    Scand J Rheumatol Suppl; 1999 Aug 23; 112():9-14. PubMed ID: 10668522
    [Abstract] [Full Text] [Related]

  • 9. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V.
    Arthritis Rheum; 2001 Sep 23; 44(9):1984-92. PubMed ID: 11592358
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
    Sharp JT, Strand V, Leung H, Hurley F, Loew-Friedrich I.
    Arthritis Rheum; 2000 Mar 23; 43(3):495-505. PubMed ID: 10728741
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Leflunomide in the treatment of rheumatoid arthritis.
    Li EK, Tam LS, Tomlinson B.
    Clin Ther; 2004 Apr 23; 26(4):447-59. PubMed ID: 15189743
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis.
    Strand V, Scott DL, Emery P, Kalden JR, Smolen JS, Cannon GW, Tugwell P, Crawford B, Leflunomide Rheumatoid Arthritis Investigators Groups.
    J Rheumatol; 2005 Apr 23; 32(4):590-601. PubMed ID: 15801012
    [Abstract] [Full Text] [Related]

  • 18. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group.
    Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R, Cannon G, Fox R, Moreland L, Olsen N, Furst D, Caldwell J, Kaine J, Sharp J, Hurley F, Loew-Friedrich I.
    Arch Intern Med; 1999 Nov 22; 159(21):2542-50. PubMed ID: 10573044
    [Abstract] [Full Text] [Related]

  • 19. Leflunomide for treating rheumatoid arthritis.
    Osiri M, Shea B, Robinson V, Suarez-Almazor M, Strand V, Tugwell P, Wells G.
    Cochrane Database Syst Rev; 2003 Nov 22; 2002(1):CD002047. PubMed ID: 12535423
    [Abstract] [Full Text] [Related]

  • 20. [Efficacy of leflunomide].
    Hirohata S.
    Nihon Rinsho; 2002 Dec 22; 60(12):2357-63. PubMed ID: 12510362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.